Tag Archives: Virology

27May/21

As India Burns Amid a Lethal 2nd Wave, It’s Now Evident that the World Has Failed in Ensuring Equitable Access to Vaccines. While Vaccine Doses Reach 9.7 Billion by 2025, Will They be Equitably Distributed?

A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released the 1st edition of its report titled “COVID-19 Vaccines – Global Market Trajectory & Analytics”. The report presents fresh perspectives on what to expect post commercialization of COVID-19 vaccines amid the rising spirit of vaccine nationalism, selfish international politics over vaccines, inadequate market access, stockpiling, and vaccine patents that still remain firmly in place. Continue reading

21Sep/20

Axon Neuroscience to launch world’s first crowdfunded vaccine against COVID-19

AXON Neuroscience (“Axon”), a clinical-stage biotech company and an industry leader in treating and preventing neurodegenerative diseases with a unique peptide vaccine platform, is launching the world’s first independently-developed crowdfunded vaccine against COVID-19 – ACvac1. Read more

18Sep/17

MIT develops tech that can pack several vaccine doses into one injection

The Massachusetts Institute of Technology has developed a drug delivery method that packs multiple doses in a single injection, and could soon make multi-shot vaccines a thing of the past. Continue reading

01Dec/15

Television personality Ricki Lake joins forces with the U.N. and Facebook to help fight against the spread of HIV/AIDS

Ricki Lake teams up with social media stars to help prevent the spread of HIV/AIDS.

Continue reading

31Jul/15

WHO: Ebola vaccine trials promising

REUTERS/ MEDECINS SANS FRONTIERES HANDOUT/ WORLD HEALTH ORGANIZATION) – It may soon be possible to protect humans against the deadly Ebola virus.

A new vaccine being tested in Guinea has been 100-percent effective,
Continue reading

01Apr/15

Experimental vaccine triggers the production of Ebola virus neutralizing antibodies

Early tests of experimental vaccine triggers the production of Ebola virus neutralizing antibodies, researchers say.

Continue reading